ABSTRACT Patients presenting with chronic obstructive airways disease and hypoxic cor pulmonale were assessed during a period of clinical stability. Seventy two patients (53 male) with a mean age of 60 years were selected for long term oxygen therapy. Mean FEV1 was 0-78 1 and forced vital capacity 1 9 1. The mean arterial oxygen tension (Pao2) was 6-1 kPa (46mm Hg) and the mean arterial carbon dioxide tension (PCo2) 6-9 kPa (52mmHg). All patients had a Pao2 of less than 8-0kPa (60mmHg) and 57 patients had a PCO2 of more than 6-0kPa (45mmHg). Pulmonary haemodynamics were measured in 45 patients yielding the following mean values: pulmonary artery pressure 28 3 mm Hg; cardiac output 5 9 1 min 1; total pulmonary vascular resistance 59 2 kPa 1-1 s. Oxygen delivery systems, including 23 oxygen concentrators, were installed in the patients' homes. Flow rates were adjusted to raise Pao2 to more than 8-0 kPa (60 mm Hg) for at least 15 hours each day and close supervision was maintained. Overall five year survival was 62%, which is better than previously reported for this type of patient; but the 10 year survival was only 26% owing to an observed acceleration in death rate at about this time. Progressive disturbances of the pulmonary circulation were arrested. Mortality was associated with the severity of airflow obstruction, reflecting a continuing pathological process affecting the airways.
Survival is poor in patients with cor pulmonale complicating chronic obstructive airways disease.-The benefits of long term oxygen therapy in these patients were examined in the nocturnal oxygen therapy (NOT) trial6 and the report of the Medical Research Council Working Party (MRC).s In the MRC study survival in women appeared to be better than in men, although the female group was small and hence few deaths occurred during the period of follow up. In men the benefit of long term oxygen therapy on survival was not apparent until about 500 days, a delay that has never been adequately explained. The five year survival in men was 42%. The mean duration of follow up in the NOT trial was 19 months. The projected three year survival in the group having continuous oxygen therapy was 63%. Timms etal7 have recently reviewed the data from the NOT trial and report that survival up to eight years is related to the fall in mean pulmonary artery pressure during the first six months of long term oxygen therapy. Survival in the group treated with oxygen for 12 hours each day was correlated with pulmonary vascular resistance, but this relationship was not apparent for those having continuous oxygen therapy.
Our centre has a high incidence of cor pulmonale complicating chronic obstructive airways disease,8
and we have conducted a study over increased from 6 1 to 9 1 kPa (a mean increase of 3-0 kPa) while the mean arterial carbon dioxide tension (Paco2) increased from 6-9 to 7-3 kPa (a mean increase of 0-39kPa) ( Survival for males and females is plotted separately in figure 2. There was no difference in survival between the sexes (p = 0 583) and the survival curves lie between those of the treated male and female groups of the MRC study.
The association of various clinical characteristics with survival was analysed with a x2 likelihood ratio test (table 3) . Survival was clearly associated with indices of airflow obstruction (FEV1: p = 0019; FVC: p = 0-013), whereas no association was observed with blood gas tensions during the breathing of air, the rise in Pao2 during the breathing of oxygen, pulmonary artery pressure or total pulmonary vascular resistance. When subgroups were compared, sur- 1 2 3 4 5 6 7 8 9 10 There are discrepancies with the results of the MRC study,5 which had similar patients. Five hundred days elapsed before benefit was apparent in men and this delay has never been explained. Our findings suggest, however, that the benefit of long term oxygen therapy is immediate, but clearly large numbers of patients and controls would be required to prove a significant difference in survival early after the start of oxygen therapy. The greater number of female patients has 
Twelve year study ofpatients with hypoxic cor pulmonale given long term domiciliary oxygen therapy eliminated the apparent difference in survival between the sexes and emphasises that the female survival curve accompanies that of the males.
A 10 year survival of only 26% is disappointing and probably relates to a continuing pathological process that exerts its effect on airway function rather than in the pulmonary circulation. Survival for patients having long term oxygen therapy was clearly associated with indices of airflow obstruction but not with pulmonary artery pressure or total pulmonary vascular resistance. The prognostic value of FEV1 is recognised from large studies of patients with chronic obstructive airways disease2 [16] [17] [18] and when FEV1 falls below 450 ml it contributes significantly to a poor prognosis.19 In severe hypoxic cor pulmonale without oxygen therapy progressive pulmonary hypertension becomes an important determinant of mortality,5 7 20-22 and this may mask the relationship between FEV1 and survival. Acute administration of oxygen lowers pulmonary artery pressure23 and a fall greater than 5 mm Hg has been associated with better survival for patients having long term oxygen therapy. 24 The fall in pulmonary artery pressure can be sustained with long term oxygen therapy. 25 In this study pulmonary artery pressure and total pulmonary vascular resistance were unchanged at the end of the first year of treatment in those who had haemodynamic measurements at this time and stabilisation of pulmonary artery pressure and total pulmonary vascular resistance was confirmed in some patients up to six years later. Long term oxygen therapy appears to interrupt the progression of haemodynamic disturbances, as was also observed in the MRC study, and in doing so has displaced the correlation of pulmonary hypertension with mortality.
There are two possible explanations. Long term oxygen therapy may prevent death from disturbances of the pulmonary circulation, so that mortality is then related to the continuing disease process in the airways and lung parenchyma. Alternatively, it is possible that the correlation of mortality with pulmonary hypertension is spurious, only masking important pathophysiological events elsewhere. The relevance of pulmonary hypertension has always been in doubt since the pulmonary artery pressure in chronic obstructive airways disease is usually considerably lower than in primary pulmonary hypertension, where right ventricular afterload leads to a fall in cardiac output to very low values. 26 In hypoxic cor pulmonale cardiac output remains normal or is raised27 -29 and right ventricular function is only marginally impaired.30 31 Failure to adapt by an increase in cardiac output leads to a reduction in oxygen delivery to the tissues and a fall in mixed venous oxygen tension, which has been associated with a poor survival rate.32 Unfortunately the beneficial effect of oxygen may be counterbalanced by a fall in cardiac output, so that oxygen delivery remains unchanged. Generally the measurement of pulmonary artery pressure in chronic obstructive airways disease is unhelpful but a detailed pathophysiological study of the airways and pulmonary circulation is needed in patients having long term oxygen therapy.
This study confirms that long term oxygen therapy is of benefit in carefully selected patients with hypoxic chronic obstructive airways disease. It is not yet clear whether it improves survival in hypoxic patients without oedema or in those with other forms of chronic respiratory disease. The analysis shows that there is no relationship between initial blood gas tensions and survival when hypoxia is subsequently corrected by long term oxygen therapy. Twenty nine of the 57 patients who were hypercapnic (Paco2 greater than 6-0 kPa (45 mm Hg)) at entry died during the study but only three of the 15 normocapnic patients died. This suggests that chronic hypercapnia is associated with a poorer prognosis even though the five year survival in this subgroup was 59%. Survival was better in patients who started long term oxygen therapy within two months of first developing oedema (p = 0-039). This form of treatment should probably be considered in all hypoxic patients soon after the onset of oedema and before the development of severe hypercapnic respiratory failure. The proportion surviving after five years can be expected to double with long term oxygen therapy but the death rate accelerates at 10 years, indicating that the benefit is temporary. The progressive rise in pulmonary artery pressure is prevented and disturbances of the pulmonary circulation are no longer important determinants of survival. Mortality appears to be related to a continuing pathological process within the airways. 
